Economic Evaluation of National Patient Blood Management Clinical Guidelines in Cardiac Surgery

Mar 1, 2022, 00:00
10.1016/j.jval.2021.07.014
https://www.valueinhealthjournal.com/article/S1098-3015(21)01683-1/fulltext
Title : Economic Evaluation of National Patient Blood Management Clinical Guidelines in Cardiac Surgery
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01683-1&doi=10.1016/j.jval.2021.07.014
First page : 419
Section Title : ECONOMIC EVALUATION
Open access? : No
Section Order : 419

Objectives

To the best of our knowledge, no published clinical guidelines have ever undergone an economic evaluation to determine whether their implementation represented an efficient allocation of resources. Here, we perform an economic evaluation of national clinical guidelines designed to reduce unnecessary blood transfusions before, during, and after surgery published in 2012 by Australia’s sole public blood provider, the National Blood Authority (NBA).

Methods

We performed a cost analysis from the government perspective, comparing the NBA’s cost of implementing their perioperative patient blood management guidelines with the estimated resource savings in the years after publication. The impact on blood products, patient outcomes, and medication use were estimated for cardiac surgeries only using a large national registry. We adopted conservative counterfactual positions over a base-case 3-year time horizon with outcomes predicted from an interrupted time-series model controlling for differences in patient characteristics and hospitals.

Results

The estimated indexed cost of implementing the guidelines of A$1.5 million (2018-2019 financial year prices) was outweighed by the predicted blood products resource saving alone of A$5.1 million (95% confidence interval A$1.4 million-A$8.8 million) including savings of A$2.4 million, A$1.6 million, and A$1.2 million from reduced red blood cell, platelet, and fresh frozen plasma use, respectively. Estimated differences in patient outcomes were highly uncertain and estimated differences in medication were financially insignificant.

Conclusions

Insofar as they led to a reduction in red blood cell, platelet, and fresh frozen plasma use during cardiac surgery, implementing the perioperative patient blood management guidelines represented an efficient use of the NBA’s resources.

Categories :
  • Cardiovascular Disorders
  • Cost/Cost of Illness/Resource Use Studies
  • Cost-comparison, Effectiveness, Utility, Benefit Analysis
  • Economic Evaluation
  • Specialized Treatment Areas
  • Surgery
Tags :
  • cardiac surgery
  • clinical guidelines
  • economic evaluation
  • patient blood management
Regions :
  • CEEWAA
ViH Article Tags :